Heart Failure Reviews

Papers
(The TQCC of Heart Failure Reviews is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)
ArticleCitations
Biomarkers for the diagnosis and management of heart failure174
COVID-19 and myocarditis: a systematic review and overview of current challenges125
Polypharmacy definition and prevalence in heart failure: a systematic review52
SGLT2-inhibitors; more than just glycosuria and diuresis51
Dilated cardiomyopathy in the era of precision medicine: latest concepts and developments51
Mechanisms of COVID-19-induced heart failure: a short review50
Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets48
Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness40
Mitochondrial abnormalities: a hub in metabolic syndrome-related cardiac dysfunction caused by oxidative stress36
Detection of myocardial fibrosis by speckle-tracking echocardiography: from prediction to clinical applications32
Resistance training in heart failure patients: a systematic review and meta-analysis32
Immunity and inflammation: the neglected key players in congenital heart disease?31
Multiple roles of cardiac macrophages in heart homeostasis and failure31
Current and emerging drug targets in heart failure treatment30
Cardiogenic shock and acute kidney injury: the rule rather than the exception30
Ventricular non-compaction review29
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases27
The non-invasive assessment of myocardial work by pressure-strain analysis: clinical applications27
A meta-analysis of microRNA expression profiling studies in heart failure27
Left ventricular hypertrophy and sudden cardiac death25
Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide24
SGLT2 inhibitors break the vicious circle between heart failure and insulin resistance: targeting energy metabolism24
Heart failure and atrial fibrillation: new concepts in pathophysiology, management, and future directions24
Therapeutic augmentation of NO-sGC-cGMP signalling: lessons learned from pulmonary arterial hypertension and heart failure23
Filamin C in cardiomyopathy: from physiological roles to DNA variants23
Mechanisms underlying the pathophysiology of heart failure with preserved ejection fraction: the tip of the iceberg23
Cardiorenal syndrome: long road between kidney and heart23
Machine learning and statistical methods for predicting mortality in heart failure23
Pirfenidone as a novel cardiac protective treatment22
Myocarditis following COVID-19 vaccination in adolescents and adults: a cumulative experience of 202121
The use of diflunisal for transthyretin cardiac amyloidosis: a review21
Sodium glucose cotransporter 2 inhibitors: mechanisms of action in heart failure21
Prognostic value of natriuretic peptides in heart failure: systematic review and meta-analysis21
The heart and gut relationship: a systematic review of the evaluation of the microbiome and trimethylamine-N-oxide (TMAO) in heart failure20
SGLT2 inhibitors and cardiovascular and renal outcomes: a meta-analysis and trial sequential analysis19
Creatine deficiency and heart failure19
The protective effects of 17-β estradiol and SIRT1 against cardiac hypertrophy: a review19
Heart–lung interactions in COVID-19: prognostic impact and usefulness of bedside echocardiography for monitoring of the right ventricle involvement19
Device-based treatment options for heart failure with preserved ejection fraction19
SGLT2 inhibitors: a focus on cardiac benefits and potential mechanisms19
Peripartum cardiomyopathy: a review18
Epidemiology and clinical manifestations of cardiac amyloidosis18
Left atrial structure and function in heart failure with reduced (HFrEF) versus preserved ejection fraction (HFpEF): systematic review and meta-analysis17
Management of RAASi-associated hyperkalemia in patients with cardiovascular disease17
The role of cardiac magnetic resonance imaging in the detection and monitoring of cardiotoxicity in patients with breast cancer after treatment: a comprehensive review17
Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis17
Lung ultrasound–guided management to reduce hospitalization in chronic heart failure: a systematic review and meta-analysis17
Hospitalisation costs associated with heart failure with preserved ejection fraction (HFpEF): a systematic review16
Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction16
Balloon pulmonary angioplasty vs. pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis16
Remote monitoring for heart failure using implantable devices: a systematic review, meta-analysis, and meta-regression of randomized controlled trials16
New antidiabetic therapy and HFpEF: light at the end of tunnel?15
Efficacy of motivational interviewing on enhancing self-care behaviors among patients with chronic heart failure: a systematic review and meta-analysis of randomized controlled trials15
0.12092399597168